ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$2.33
+5.91% today
Updated 2026-10-28
Market cap
$1.46M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-136.26
Dividend yield
—
52W range
$3 – $99
Volume
0.7M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-47.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$18.00
+672.53%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -47.88 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-5.03M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-10.08M | $-9.29M | $-9.83M | $-12.88M | $-2.43M |
| EPS | — | — | — | — | $-136.26 |
| Free cash flow | $-8.01M | $-8.21M | $-8.35M | $-8.52M | $-5.03M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Artelo Biosciences Inc trades at $2.33. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -47.88, it sits in the distress.
Frequently asked questions
What is Artelo Biosciences Inc's stock price?
Artelo Biosciences Inc (ARTL) trades at $2.33.
Is Artelo Biosciences Inc overvalued?
Artelo Biosciences Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Artelo Biosciences Inc (ARTL)?
The 12-month analyst consensus target is $18.00, about 672.5% above the current $2.33. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Artelo Biosciences Inc's Altman Z-Score is -47.88, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-201.81%
Beta-0.07
50D MA$5.05
200D MA$23.41
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—